For the rest of the products on the reimbursed drugs list, the contribution will remain unchanged.

Heath minister Nicolae Banicioiu said that the list has been already updated with 40 new molecules and combinations of new active substances, and the process continues.

The introduction of the new list of reimbursed medical drugs has been postponed several times so far.

The clawback tax was introduced in October 2011. Pharmaceutical producers have repeatedly said that the fiscal burden of the clawback tax became unsustainable and will trigger the drop of local generic medicine production, with social and economic effects, as many of the medicines with accessible prices will disappear from the market while the local industry will delay investments in development and will have to resort to layoffs.